Current clinical consensus reflects the following: Research findings are preliminary and insufficient to guide treatment decisions No regulatory approval exists for using GLP-1s in addiction treatment Early signals do not outweigh the lack of long-term outcome data Instead, clinicians continue to recommend established, evidence-based approaches, including: Behavioral therapies tailored to substance use disorders Medication-assisted treatment when medically indicated Comprehensive psychosocial support and relapse-prevention planning Comprehensive assessment remains a cornerstone of safe and effective care
Though not FDA-approved solely for weight loss, Ozempic has been used off-label for this purpose, with potential changes in facial aesthetics that can be managed through cosmetic procedures, facial exercises, and skincare routines
Serious Side Effects to Watch For While rare, serious side effects like hypoglycemia (low blood sugar) and pancreatitis (inflammation of the pancreas) can occur
Are you still concerned about the side effects of semaglutide
GLP-1 dominates the first
Nuts and seeds in controlled portions provide healthy fats, protein, and fiber